Gastroenterology

Top Story

FDA grants breakthrough designation to regimen for patients who fail DAA therapy

September 30, 2016

The FDA has granted breakthrough therapy designation to AbbVie’s investigational regimen for patients with hepatitis C virus infection who failed previous direct-acting antiviral therapy, the manufacturer announced.

The pangenotypic regimen — ABT-493 (glecaprevir, AbbVie) and ABT-530 (pibrentasvir, AbbVie) — is for patients with HCV genotype 1 who failed treatment with DAAs, including treatment with an NS5A inhibitor and/or protease inhibitor, according to a press release. The designation is indicative of clinical results from the phase 2 MAGELLAN-1 clinical study.

GI societies reject ABIM's alternative MOC testing, pathway proposals

September 30, 2016
The AGA, ACG, ASGE and AASLD, along with the majority of internal medicine societies, object to the American Board of Internal Medicine’s recently proposed changes…

ALF, Bayer collaborate to elevate liver cancer awareness

September 30, 2016
October is Liver Cancer Awareness Month, and Bayer and the American Liver Foundation announced the third consecutive year of a shared initiative to draw attention to the…
In the Journals

Cost-effectiveness in CRC screening may depend on patient participation

September 29, 2016
Given equal participation rates, fecal immunochemical tests and colonoscopy are more effective and less expensive than multitarget stool DNA tests for average-risk…

New analyses support blocking Anthem-Cigna and Aetna-Humana mergers

September 29, 2016
Two new American Medical Association analyses support the blocking of the Anthem-Cigna and Aetna-Humana mergers. “The [American Medical Association] AMA analyses…
More News Headlines »
CME

HCV Updates and Case Challenges for the Rapidly Changing Landscape

This activity is supported by an educational grant from Merck & Co., Inc.

In the past few years, significant progress has been made in the treatment of chronic hepatitis C virus (HCV). Highly…
More »
GI Bookshelf

Question 43: Caroli's Disease, What Do I Need to Know?

From Curbside Consultation of the Pancreas: 49 Clinical Questions
More »
Featured
Digestive Disease Week

Digestive Disease Week

Video
Meeting News Coverage

VIDEO: New online platform provides coaching, counseling to GI patients

June 8, 2016
More »
morganatic-roan
morganatic-roan